APG Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $3.8M | Sell |
|
|||||
|
2024
Q4 | $5.37M | Buy |
|
|||||
|
2024
Q3 | $1.37M | Sell |
|
|||||
|
2024
Q2 | $11.8M | Buy |
|
|||||
|
2024
Q1 | $13.7M | Buy |
|
|||||
|
2023
Q4 | $8.24M | Sell |
|
|||||
|
2023
Q3 | $8.08M | Sell |
|
|||||
|
2023
Q2 | $8.82M | Sell |
|
|||||
|
2023
Q1 | $8.5M | Sell |
|
|||||
|
2022
Q4 | $11.6M | Buy |
|
|||||
|
2022
Q3 | $2.03M | Buy |
|
|||||
|
2022
Q2 | $1.39M | Buy |
|
|||||
|
2022
Q1 | $638K | Sell |
|
|||||
|
2021
Q4 | $861K | Sell |
|
|||||
|
2021
Q3 | $1.39M | Sell |
|
|||||
|
2021
Q2 | $1.81M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $12.4M | Sell |
|
|||||
|
2018
Q1 | $23.2M | Sell |
|
|||||
|
2017
Q4 | $33.6M | Buy |
|
|||||
|
2017
Q3 | $11M | Buy |
|